Breaking News

Sonoma Biotherapeutics Awarded ScaleReady G-Rex Grant 

To support development of a G-Rex based manufacturing process to produce gene-modified regulatory T cell (Treg) therapies.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sonoma Biotherapeutics

ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corp. and CellReady, have awarded Sonoma Biotherapeutics a $300,000 G-Rex Grant.  SonomaBio’s G-Rex Grant aims to enable expedited development of a G-Rex based manufacturing process to produce gene-modified regulatory T cell (Treg) therapies for clinical investigation of SonomaBio products in development for various autoimmune related disorders.  “Regulatory T cells represent a promising new treatment modality, and we are...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters